Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 2,951 shares at $229.43 ($676K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Scheduled sale ($676k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $228.33 | 1,292 | $295K | 43.7% |
| 2 | $229.43 | 1,659 | $381K | 56.3% |
| Total | $228.95 avg | 2,951 | $676K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |